Contribution and clinical relevance of germline variation to the cancer transcriptome.
Saved in:
| Title: | Contribution and clinical relevance of germline variation to the cancer transcriptome. |
|---|---|
| Authors: | Pereira B; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Labrot E; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Durand E; Novartis Institutes for Biomedical Research, Novartis Campus, Fabrikstrasse 2, CH-4056, Basel, Switzerland., Korn JM; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA., Kauffmann A; Novartis Institutes for Biomedical Research, Novartis Campus, Fabrikstrasse 2, CH-4056, Basel, Switzerland., Campbell CD; Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA. katie.campbell@novartis.com. |
| Source: | BMC cancer [BMC Cancer] 2022 Jun 20; Vol. 22 (1), pp. 675. Date of Electronic Publication: 2022 Jun 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-022-09757-0 |
